In the last trading session, 4.33 million Gossamer Bio Inc (NASDAQ:GOSS) shares changed hands as the company’s beta touched 1.95. With the company’s per share price at $0.74 changed hands at -$0.03 or -4.06% during last session, the market valuation stood at $167.40M. GOSS’s last price was a discount, traded about -154.05% off its 52-week high of $1.88. The share price had its 52-week low at $0.45, which suggests the last value was 39.19% up since then. When we look at Gossamer Bio Inc’s average trading volume, we note the 3-month average coming to 1.49 million.

Gossamer Bio Inc (NASDAQ:GOSS) trade information

Instantly GOSS was in red as seen at the end of in last trading. With action 10.78%, the performance over the past five days has been green. The drop to weekly highs of 0.8045 subtracted -4.06% to the stock’s daily price. The company’s shares are showing year-to-date downside of -18.90%, with the 5-day performance at 10.78% in the green. However, in the 30-day time frame, Gossamer Bio Inc (NASDAQ:GOSS) is -30.84% down.

Gossamer Bio Inc (GOSS) estimates and forecasts

Data shows that the Gossamer Bio Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 54.17% over the past 6 months, a 36.44% in annual growth rate that is considerably higher than the industry average of 13.00%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 11.99%. The 2024 estimates are for Gossamer Bio Inc earnings to increase by 35.82%, but the outlook for the next 5-year period is at 5.20% per year.

GOSS Dividends

Gossamer Bio Inc is expected to release its next quarterly earnings report in June.